eb104
eb104: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Estrella Immunopharma Inc. (ESLA) | Phase 1/Phase 2 |
Get deeper analysis on eb104
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis